arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Profusa, Inc.

PFSA
$0.92 ▲ +0.01 (+0.91%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
20 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Bullish
auto_awesome

Analytical Summary

Profusa, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.6M
Dividend Yield
Revenue Growth
Op. Margin
ROIC 11.2%
FCF / Share $-1.53
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-3.46M
↓ -208.6%
FCF / Share Free cash flow per share
$-1.53
↓ -2090.9%
Long-Term Debt Long-term obligations
$713.01K
↑ +92.9%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
100
Financial Health
13
Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 20 quarters